Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Commences Trading on the OTCQX


May 30, 2019

Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A


March 28, 2019

Cardiol Therapeutics to Present at the 2019 LD Micro Virtual Conference


March 12, 2019

Cardiol Therapeutics Appoints Thomas Moffatt as Chief Commercial Officer


March 6, 2019

Cardiol Therapeutics Inc. Closes Over-Allotment


January 18, 2019

Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT”


December 20, 2018

Cardiol Therapeutics Appoints Mr. Chris Waddick as Chief Financial Officer, Ms. Anne Tomalin as Director of Regulatory Affairs, and Ms. Dolly Kao as Intellectual Property Counsel


August 30, 2018

Cardiol Therapeutics Appoints Dr. Eldon Smith as Chairman and Dr. Guillermo Torre-Amione, Ms. Deborah Brown, and Mr. Iain Chalmers to its Board of Directors


August 21, 2018

Cardiol Therapeutics Closes $10.5 Million Private Placement


May 24, 2018

2025 Cardiol Therapeutics. All right reserved.